CU6 starting to gain some buyers back, had a good read of the quarterly and trial results due in a couple of months. Lack of news and it did get very expensive at $8.80 but it's shown before it runs hard when it does, by all accounts the trial data is all coming in as expected or from smaller trial results.
That should do us well once the larger phase 2 and 3 trial data is released upon eventual FDA approvals and revenues/Profits.
Patience needed i didn't pick the bottom on the buyback but got the top when selling last so wanting to stay long until $10-$15 a share possible buyout of revenues and profits justify that price and MKT Cap.
Happy to see some life at the station on good volumes and price uptick
CU6 Price at posting:
$2.55 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)